Search

everythinglearnresearchcommunity

for

Search:↓

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

The C-terminal tail of AHF/trichohyalin is essential for organizing keratin filaments in keratinocytes.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

The patient's hair had unique damage and a lower sulfur-to-nitrogen ratio compared to relatives, but not compared to healthy controls.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

COX2 and ATP synthase control the size of hedgehog spines.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

A genetic region near the PAX1 gene is linked to a higher risk of scoliosis in females.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

ITK inhibitors may effectively treat alopecia areata.

JAK inhibitors are effective treatments for alopecia areata.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

AGD1 is important for root hair development in Arabidopsis, working with phosphoinositide signaling and the actin cytoskeleton.

Msx2 and Foxn1 are both crucial for hair growth and health.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Botox is effective for urinary incontinence, chronic migraines, and male pattern hair loss, and a new test for Botox antibodies is more humane.

Over-expression of Sp2 can lead to cancer by preventing proper stem cell differentiation.

PAI-2 helps in the maturation and protection of hair and nail cells.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Correcting EDA fibronectin organization and YAP translocation can improve wound healing in fibrotic conditions.

Zinc supplementation effectively treats acrodermatitis enteropathica symptoms.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

BST2 protein and certain T cells increase in early alopecia areata.

Scientists made a mouse that shows how a specific protein in the skin changes and affects hair growth and shape.

Controlling Tslp can improve health in AEC syndrome patients.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

OCT4B1 and SOX-2 levels are higher in Crohn's and ulcerative colitis patients, possibly aiding tissue repair.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Thioredoxin reductase 1 does not affect glucocorticoid receptor activity in hair follicle cells.